CINC logo

CinCor Pharma (CINC) Financials

Balance sheets

30 Sept 202230 June 202231 Mar 202231 Dec 202130 Sept 202130 June 202131 Mar 202131 Dec 202001 Sept 2020

Total Assets

$529.1 M(+74.6%)$303.0 M(-5.8%)$321.6 M(+128.0%)$141.1 M---$26.8 M-

Current Assets

$529.0 M(+74.6%)$303.0 M(-5.8%)$321.6 M(+128.0%)$141.1 M---$26.8 M-

Non Current Assets

$99.7 K(+145.0%)$40.7 K(+100.0%)$0.0(0%)$0.0---$0.0-

Total Liabilities

$10.2 M(+39.8%)$7.3 M(+28.1%)$5.7 M(-97.2%)$204.8 M---$54.1 M-

Current Liabilities

$10.2 M(+39.8%)$7.3 M(+28.1%)$5.7 M(-65.6%)$16.5 M---$6.9 M-

Long Term Liabilities

$0.0(0%)$0.0(0%)$0.0(-100.0%)$188.3 M---$47.2 M-

Shareholders Equity

$518.9 M(+75.5%)$295.7 M(-6.4%)$316.0 M(+595.9%)-$63.7 M----$27.3 M-

Book Value

$518.9 M(+75.5%)$295.7 M(-6.4%)$316.0 M(+595.9%)-$63.7 M----$27.3 M-

Working Capital

$518.8 M(+75.5%)$295.7 M(-6.4%)$316.0 M(+153.7%)$124.6 M---$19.9 M-

Cash And Cash Equivalents

$292.6 M(+129.2%)$127.6 M(-22.5%)$164.6 M(+20.5%)$136.6 M---$26.1 M-

Accounts Payable

$2.6 M(+23.5%)$2.1 M(-52.0%)$4.4 M(+580.5%)$642.1 K---$3.7 M-

Accounts Receivable

-------$0.0-

Short Term Debt

---------

Long Term Debt

---------

Total Debt

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Debt To Equity

0.0(0%)0.0(0%)0.0(0%)0.0---0.0-

Current Ratio

52.0(+24.9%)41.6(-26.4%)56.6(+563.2%)8.5---3.9-

Quick Ratio

---------

Inventory

---------

Retained Earnings

-$136.5 M(-18.2%)-$115.5 M(-22.3%)-$94.4 M(-21.5%)-$77.7 M----$27.3 M-

PB Ratio

2.8(+15.4%)2.4(+14.8%)2.1------

Income statements

30 Sept 202230 June 202231 Mar 202231 Dec 202130 Sept 202130 June 202131 Mar 202131 Dec 202001 Sept 2020

EPS

-$0.5(+8.9%)-$0.6(-12.0%)-$0.5(+39.6%)-$0.8(-225.2%)-$0.3(-37.2%)-$0.2(-13.6%)-$0.2(+3.3%)-$0.2-

TTM EPS

-$2.4(-11.9%)-$2.1(-21.2%)-$1.8(-23.5%)-$1.4(-85.3%)-$0.8(-49.2%)-$0.5(-55.8%)-$0.3(-96.7%)-$0.2-

Revenue

---------

TTM Revenue

---------

Total Expenses

$22.2 M(+4.2%)$21.4 M(+55.8%)$13.7 M(-45.7%)$25.2 M(+228.1%)$7.7 M(+48.6%)$5.2 M(+17.3%)$4.4 M(-20.0%)$5.5 M-

Operating Expenses

$22.2 M(+4.2%)$21.4 M(+55.8%)$13.7 M(-45.7%)$25.2 M(+228.1%)$7.7 M(+48.6%)$5.2 M(+17.3%)$4.4 M(-20.0%)$5.5 M-

Cost Of Goods Sold

---------

TTM Cost Of Goods Sold

---------

Gross Profit

---------

TTM Gross Profit

---------

Gross Margin

---------

Operating Profit

-$22.2 M(-4.2%)-$21.4 M(-55.8%)-$13.7 M(+45.7%)-$25.2 M(-228.1%)-$7.7 M(-48.6%)-$5.2 M(-17.3%)-$4.4 M(+20.0%)-$5.5 M-

TTM Operating Profit

-$82.5 M(-21.4%)-$68.0 M(-31.2%)-$51.8 M(-21.9%)-$42.5 M(-86.5%)-$22.8 M(-50.9%)-$15.1 M(-52.1%)-$9.9 M(-80.0%)-$5.5 M-

Operating Margin

---------

Net Income

-$21.0 M(+0.5%)-$21.1 M(-26.2%)-$16.7 M(+43.1%)-$29.3 M(-225.2%)-$9.0 M(-41.4%)-$6.4 M(-13.6%)-$5.6 M(+3.3%)-$5.8 M-

TTM Net Income

-$88.1 M(-15.7%)-$76.1 M(-23.9%)-$61.4 M(-22.0%)-$50.4 M(-87.7%)-$26.8 M(-50.7%)-$17.8 M(-55.9%)-$11.4 M(-96.7%)-$5.8 M-

Net Margin

---------

EBIT

-$22.2 M(-4.2%)-$21.4 M(-55.8%)-$13.7 M(+45.7%)-$25.2 M(-228.1%)-$7.7 M(-48.6%)-$5.2 M(-17.3%)-$4.4 M(+20.0%)-$5.5 M-

TTM EBIT

-$82.5 M(-21.4%)-$68.0 M(-31.2%)-$51.8 M(-21.9%)-$42.5 M(-86.5%)-$22.8 M(-50.9%)-$15.1 M(-52.1%)-$9.9 M(-80.0%)-$5.5 M-

EBITDA

-$22.2 M(-4.2%)-$21.4 M(-55.8%)-$13.7 M(+45.7%)-$25.2 M(-228.1%)-$7.7 M(-48.6%)-$5.2 M(-17.3%)-$4.4 M(+20.0%)-$5.5 M-

TTM EBITDA

-$82.5 M(-21.4%)-$68.0 M(-31.2%)-$51.8 M(-21.9%)-$42.5 M(-86.5%)-$22.8 M(-50.9%)-$15.1 M(-52.1%)-$9.9 M(-80.0%)-$5.5 M-

Selling, General & Administrative Expenses

$4.5 M(+7.8%)$4.2 M(+4.0%)$4.0 M(-74.6%)$15.9 M(+421.1%)$3.0 M(+158.7%)$1.2 M(+27.3%)$923.6 K(+212.7%)-$819.7 K-

TTM SG&A

$28.6 M(+5.5%)$27.1 M(+12.5%)$24.1 M(+14.8%)$21.0 M(+385.8%)$4.3 M(+237.7%)$1.3 M(+1131.9%)$103.9 K(+112.7%)-$819.7 K-

Depreciation And Amortization

$4200.0(+200.0%)$1400.0--$0.0(0%)$0.0---

TTM D&A

$5600.0(+300.0%)$1400.0--$0.0(0%)$0.0---

Interest Expense

---------

TTM Interest Expense

---------

Income Tax

---------

TTM Income Tax

---------

PE Ratio

---------

PS Ratio

---------

Cashflow statements

30 Sept 202230 June 202231 Mar 202231 Dec 202130 Sept 202130 June 202131 Mar 202131 Dec 202001 Sept 2020

Cash From Operations

-$15.1 M(+22.7%)-$19.6 M(-10.4%)-$17.7 M(-49.0%)-$11.9 M(-121.3%)-$5.4 M(+31.2%)-$7.8 M(-35.2%)-$5.8 M--

TTM CFO

-$64.3 M(-17.9%)-$54.5 M(-27.4%)-$42.8 M(-38.7%)-$30.8 M(-62.7%)-$19.0 M(-39.6%)-$13.6 M(-135.2%)-$5.8 M--

Cash From Investing

-$63.2 M(-262.8%)-$17.4 M(+88.4%)-$149.8 M-$0.0(0%)$0.0(0%)$0.0--

TTM CFI

-$230.5 M(-37.8%)-$167.3 M(-11.6%)-$149.8 M-$0.0(0%)$0.0(0%)$0.0--

Cash From Financing

$243.3 M(+100.0%)$0.0(-100.0%)$195.5 M(+2780.3%)$6.8 M(-94.9%)$133.4 M(+10717.1%)$1.2 M(+100.0%)$0.0--

TTM CFF

$445.6 M(+32.8%)$335.7 M(-0.4%)$336.9 M(+138.3%)$141.4 M(+5.0%)$134.6 M(+10817.1%)$1.2 M(+100.0%)$0.0--

Free Cash Flow

-$15.2 M(+22.6%)-$19.6 M(-10.6%)-$17.7 M(-49.0%)-$11.9 M(-121.3%)-$5.4 M(+31.2%)-$7.8 M(-35.2%)-$5.8 M--

TTM FCF

-$64.4 M(-18.0%)-$54.6 M(-27.6%)-$42.8 M(-38.7%)-$30.8 M(-62.7%)-$19.0 M(-39.6%)-$13.6 M(-135.2%)-$5.8 M--

CAPEX

---------

TTM CAPEX

---------

Dividends Paid

---------

TTM Dividends Paid

---------

TTM Dividend Per Share

---------

TTM Dividend Yield

---------

Payout Ratio

---------